The aim of universal coverage had been proposed in China. However, there was still lack of the coverage on children, a vulnerable group, so was the absence of medicines selection for children, even after the implement of essential medicines system for nearly 3 years. By the lessons from World Health Organizations experiences, this article implied the main reasons were the undeveloped digital progress of Chinese pediatrics hospitals, the ethnics restricts for children clinical experiments as well as the lack of integration of medicines research and development on children.In conclusion, it suggested building an information integration system of pharmaceutical research and clinic reports for children, and advised to design software in such virgin field of medicines selection for children, with the deepening of medical system reform and the widening of the essential medicines system since 2011.%我国新医改提出"全民医保"的目标,但是对儿童这一弱势群体的保障不够,特别是基本药物制度实施近3年却至今未遴选出儿童药物.通过对比世界卫生组织建立网络数据库辅助儿童药物遴选的经验,指出中国缺少儿童药物的主要原因在于医药信息化水平不高,而儿童医院和一般医院儿科用药临床数据缺乏信息共享.结论:2011年我国医改及基本药物制度的深化,势必要求遴选儿童基本药物,信息化建设应尽快随之拓宽领域.建议建立儿童药物实验和临床信息共享系统,填补儿童药物遴选相关医药软件行业空白.
展开▼
